1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors

Details for Australian Patent Application No. 2010246607 (hide)

Owner Janssen Pharmaceuticals, Inc. Addex Pharma S.A.

Inventors Cid-Nunez, Jose Maria; De Lucas Olivares, Ana Isabel; Trabanco-Suarez, Andres Avelino; Macdonald, Gregor James

Agent FB Rice

Pub. Number AU-B-2010246607

PCT Pub. Number WO2010/130422

Priority 09160067.6 12.05.09 EP

Filing date 11 May 2010

Wipo publication date 18 November 2010

Acceptance publication date 27 September 2012

International Classifications

C07D 519/00 Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or

A61K 31/437

A61P 25/00 Drugs for disorders of the nervous system

C07D 471/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

17 November 2011 PCT application entered the National Phase

  PCT publication WO2010/130422 Priority application(s): WO2010/130422

27 September 2012 Application Accepted

  Published as AU-B-2010246607

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010246608-7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors

2010246603-Treatment of eye diseases using encapsulated cells encoding and secreting a neuroprotective factor and/or an anti-angiogenic factor